A stapled peptide mimetic of the CtIP tetramerization motif interferes with double-strand break repair and

Anika Kuster1, Nour L Mozaffari1, Oliver J Wilkinson2

  • 1Institute of Molecular Cancer Research, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.

Science Advances
|February 20, 2021
PubMed

Insights

Researchers developed a peptide inhibitor (SP18-28) targeting CtIP, a DNA repair protein. This peptide disrupts DNA repair and selectively kills BRCA1-mutated cancer cells, offering a potential new cancer therapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Background:

  • Cancer cells exhibit high DNA damage and replication stress.
  • DNA repair proteins like CtIP are potential therapeutic targets.
  • CtIP is crucial for DNA double-strand break repair and replication fork stability.

Purpose of the Study:

  • To develop a peptide mimetic inhibiting CtIP activity.
  • To investigate the therapeutic potential of targeting CtIP in cancer.

Main Methods:

  • Creation of a hydrocarbon-stapled peptide (SP18-28) mimicking the CtIP tetramerization motif.
  • In vitro binding assays and assessment of CtIP tetramer aggregation.
  • Evaluation of intracellular uptake, chromatin localization, DNA repair, and replication fork stability.
  • Testing sensitivity to DNA-damaging agents and cancer cell viability assays, including BRCA1-mutated lines.

Main Results:

  • SP18-28 binds CtIP tetramers and induces aggregation.
  • SP18-28 treatment impairs CtIP's role in DNA repair and causes replication fork degradation.
  • SP18-28 treatment increases sensitivity to DNA-damaging agents.
  • SP18-28 selectively reduces viability in BRCA1-mutated cancer cells.

Conclusions:

  • SP18-28 effectively inhibits CtIP function in cancer cells.
  • Targeting CtIP with peptide mimetics shows promise for cancer therapy.
  • This approach may be particularly effective for BRCA1-mutated cancers.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.1K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.9K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.4K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
58.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K